Clustering data with hclust algorithm for Metabolomic and lipidomic profiles in response to exogenous insulin and GLP-1 infusions during prolonged fasting (Study ST000107)
GCMS Positive ion mode (Analysis AN000178)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C20:3n6 | ME660001 | 1.56 | 1.05 | 0.97 | 0.97 | 0.79 | 0.78 | 0.87 | 0.98 | 0.97 | 1.25 | 1.10 | 0.93 | 0.96 | 0.89 | 1.05 |
| C18:0 | ME659995 | 1.16 | 1.20 | 1.07 | 1.30 | 0.53 | 0.98 | 1.09 | 0.92 | 1.04 | 0.94 | 1.02 | 0.78 | 1.06 | 0.84 | 1.02 |
| C20:4n6 | ME660002 | 1.16 | 1.27 | 1.10 | 0.96 | 0.66 | 0.88 | 1.03 | 0.99 | 1.00 | 1.18 | 0.88 | 0.79 | 0.90 | 0.84 | 1.17 |
| C22:6n3 | ME660005 | 1.12 | 1.06 | 1.26 | 0.83 | 0.61 | 1.01 | 1.07 | 0.99 | 1.03 | 1.12 | 1.03 | 0.81 | 0.92 | 0.65 | 1.09 |
| C20:5n3 | ME660003 | 1.18 | 0.73 | 1.04 | 0.50 | 0.43 | 1.21 | 1.02 | 1.36 | 1.01 | 1.21 | 0.93 | 0.74 | 1.13 | 0.37 | 0.68 |
| C16:1n7 | ME659993 | 1.42 | 0.84 | 1.21 | 0.52 | 0.18 | 1.24 | 1.06 | 1.42 | 0.97 | 1.30 | 0.68 | 0.58 | 0.94 | 0.22 | 0.89 |
| C18:3n3 | ME659999 | 1.32 | 0.82 | 1.34 | 0.49 | 0.24 | 1.23 | 1.08 | 1.24 | 0.99 | 1.23 | 0.62 | 0.56 | 0.95 | 0.19 | 0.79 |
| C20:1n9 | ME660000 | 1.52 | 1.42 | 1.28 | 0.91 | 0.16 | 1.22 | 1.18 | 0.87 | 1.17 | 0.95 | 0.80 | 0.60 | 0.73 | 0.29 | 1.05 |
| C16:0 | ME659992 | 1.40 | 1.10 | 1.02 | 0.78 | 0.31 | 1.04 | 1.19 | 1.11 | 0.97 | 1.16 | 0.97 | 0.74 | 1.08 | 0.39 | 0.92 |
| C17:0 | ME659994 | 1.26 | 1.05 | 1.11 | 1.05 | 0.33 | 1.08 | 1.15 | 0.99 | 1.05 | 1.06 | 0.96 | 0.87 | 0.93 | 0.45 | 0.96 |
| C22:5n3 | ME660004 | 1.26 | 1.10 | 1.13 | 0.69 | 0.27 | 1.05 | 1.17 | 1.18 | 1.20 | 1.25 | 0.74 | 0.67 | 0.66 | 0.30 | 1.00 |
| C18:1n9 | ME659996 | 1.45 | 1.15 | 1.09 | 0.76 | 0.13 | 1.21 | 1.29 | 1.14 | 1.09 | 1.16 | 0.71 | 0.50 | 0.84 | 0.19 | 0.84 |
| C18:1n7 | ME659997 | 1.51 | 1.15 | 1.12 | 0.71 | 0.17 | 1.16 | 1.22 | 1.09 | 1.02 | 1.18 | 0.75 | 0.61 | 0.92 | 0.22 | 0.88 |
| C18:2n6 | ME659998 | 1.44 | 1.19 | 1.20 | 0.78 | 0.22 | 1.11 | 1.19 | 1.11 | 1.06 | 1.11 | 0.75 | 0.56 | 0.90 | 0.31 | 0.93 |
Factors:
| F1 | Treatment:Early ITT Infusion Study | Timepoint:0 mins |
| F2 | Treatment:Early ITT Infusion Study | Timepoint:10 mins |
| F3 | Treatment:Early ITT Infusion Study | Timepoint:120 mins |
| F4 | Treatment:Early ITT Infusion Study | Timepoint:30 mins |
| F5 | Treatment:Early ITT Infusion Study | Timepoint:60 mins |
| F6 | Treatment:GLP1/Late GTT | Timepoint:0 mins |
| F7 | Treatment:GLP1/Late GTT | Timepoint:10 mins |
| F8 | Treatment:GLP1/Late GTT | Timepoint:120 mins |
| F9 | Treatment:GLP1/Late GTT | Timepoint:30 mins |
| F10 | Treatment:GLP1/Late GTT | Timepoint:60 mins |
| F11 | Treatment:Late ITT Infusion Study | Timepoint:0 mins |
| F12 | Treatment:Late ITT Infusion Study | Timepoint:10 mins |
| F13 | Treatment:Late ITT Infusion Study | Timepoint:120 mins |
| F14 | Treatment:Late ITT Infusion Study | Timepoint:30 mins |
| F15 | Treatment:Late ITT Infusion Study | Timepoint:60 mins |
